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Abstract 
Objective: 
Restless legs syndrome (RLS) is a common neurological disorder. Secondary RLS includes 
pregnancy and iron deficiency. Prevalence of RLS in pregnancy ranges between 11-27%. We 
aimed at assessing frequency and characteristics of RLS in pregnancy in a Peruvian 
population and to evaluate possible pregnancy or delivery complications due to RLS. 
Methods: 
We assessed 218 consecutive expectant mothers at the inpatient clinic of the Hospital San 
Bartolome, Lima, Peru. Assessment was performed by using the standard diagnostic criteria 
for RLS and by a clinical-diagnostic interview. Questionnaires for RLS severity (IRLS) and 
excessive daytime sleepiness (EDS) by Epworth Sleepiness Scale (ESS) were used. Blood 
examination was performed for hemoglobin and hematocrit. For comparison, RLS patients 
were matched for age- and BMI with pregnant women without RLS. 
Results: 
Out of 218 patients, 40 (18.4%) fulfilled diagnostic criteria for RLS. In RLS patients, 
prophylactic iron supplementation therapy during pregnancy was taken less frequently 
(p=0.02). Pregnant women with RLS had a higher ESS score than pregnant controls (10.6 +/- 
3.1 vs. 7.6. +/- 3.6; p<0.001). Preeclampsia was more frequent in RLS (7/40 vs. 1/39; 
p=0.03).  
Conclusions: 
In our study, RLS was frequent in pregnant Peruvian women, especially in those without 
prophylactic iron supplementation. RLS patients described more daytime sleepiness. 
Preeclampsia was more common in RLS. This is the first study indicating a possible 
association between RLS and preeclampsia. 
 
Introduction 
Restless Legs Syndrome (RLS), is one of the most common movement and sleep disorders 
with a frequency of 2 to 10% in the general population.1 Diagnostic criteria 2 include an urge 
to move, usually focused on the legs, which begins or worsens during periods of rest or 
inactivity. Further, symptoms improve by movement and have strong circadian presentation 
with a worsening in the evening and night. RLS is usually associated with insomnia and 
sometimes with excessive daytime sleepiness.3,4 Associations with psychiatric disorders 
(anxiety, depression) and cardiovascular disorders (hypertension, coronary artery disease) are 
postulated.5,6 
The pathogenesis of RLS remains unclear, but most probably, a brain iron deficiency 
produces a dopaminergic pathology producing the RLS symptoms.7,8 
RLS is categorized as either primary (idiopathic) or secondary depending on clinical features. 
Secondary (symptomatic) RLS can occur due to (e.g.) iron deficiency, folate deficiency or 
pregnancy. In European and North American countries, a prevalence of 11-27%, in Brazil 
13.5% or Pakistan 30% of RLS in pregnancy has been described. 9-11 In pregnancy, the 
majority experience RLS for the first time or experience a worsening of symptoms.9 RLS 
often occurs during the 3rd trimester. The appearance of RLS in pregnancy is a risk factor for 
a later occurring, often chronic RLS. Symptoms are usually transient: In 2/3 of patients, RLS 
disappears within 2 weeks after delivery.9,12  
There are different hypotheses for the occurrence of RLS in pregnancy. Under hypothesis: 1. 
hormonal. An increase of prolactin and/or estrogen alters dopamine metabolism. 2. 
psychomotor behaviour hypothesis: pregnancy is a period of reduced activity. 3. metabolic 
hypothesis: iron and/or folate deficiency in pregnancy is frequent.9,13,14   
The treatment of RLS includes iron supplementation, dopaminergic agents, opioids, and 
antiepileptic drugs. Dopaminergic medications are currently considered the treatment of 
choice for RLS.5,6 In pregnancy, oral (or intravenous) iron supplementation is recommended. 
15 For oral supplementation there is no evidence for any benefit on RLS.  
Preeclampsia is a severe complication of pregnancy and includes the symptoms: hypertension 
(>140/90 mmHg),  proteinuria (>300mg/ 24h), and  edema (especially hands and face) and 
has a prevalence of 6-8% worldwide. For a diagnosis, only hypertension (two separate 
readings taken at least six hours apart of 140 or more in systolic blood pressure and/or 90 or 
more in diastolic blood pressure) and proteinuria (300 mg of protein in a 24-hour urine 
sample) are nessesary. In Peru, preeclampsia occurs in 10% of pregnancies.16 The incidence 
of preeclampsia at the Hospital Nacional San Bartolome is 7%.17 Pathogenesis of 
preeclampsia is still poorly understood and includes genetic, anatomic, nutritional, vascular, 
inflammatory, metabolic, social and emotional factors. 18-20 Preeclampsia and eclampsia are 
maternal and fetal syndromes, probably secondary due to imperfect placentation, inadequate 
blood perfusion, hypoxia and excessive placentary production of soluble fms-like tyrosine 
kinase-1 (sFlt-1).21 SFlt-1 is a potent angiogenic growth factor, antagonizes vascular 
endothelial growth factor (VEGF) and PlGF (placental growth factor), and leads to a damaged 
maternal endothelium and restriction of placental growth. Consequently maternal 
hypertension and proteinuria occur.19-21 
Possible risk factors include pre-existing hypertension, diabetes, autoimmune diseases such as 
lupus, and a family history of preeclampsia. When preeclampsia occurs, it often comes to 
abortion or an induced delivery, partially by caesarian section. In Peru, preeclampsia is the 
principal cause of morbidity and mortality in pregnant women and their fetus 22,23 and also the 
cause second frequently for maternal mortality.24 
Pregnancy or delivery complications due to RLS are not described.  
Objective: To assess the frequency and characteristics of RLS in pregnancy in a Peruvian 
population with a particular focus on pregnancy and delivery complications.  
 
Patients and Methods 
This study was conducted at the Hospital Nacional Docente Madre Niño San Bartolome, 
Lima, Peru from June 1st, 2011 until June 30th, 2011.  
Ethics: The study protocol was approved by the local Institutional Review Boards, and all 
patients gave written informed consent. The study was performed according the principles of 
the Helsinki Declaration of 1975.  
Subjects and clinical assessment: During the above-mentioned period, 218 consecutive 
expectant mothers were admitted for delivery. Assessment included a clinical-diagnostic face-
to-face interview by a trained and experienced neurologist for RLS symptoms and was 
performed during the peripartum period (+/- 1 day), usually the day after delivery.  The 
diagnosis of RLS was made according to standard criteria.2 Other RLS associated conditions 
were excluded. We compared RLS patients with age- and BMI- matched controls (expectant 
mothers). Iron supplementation was defined as “daily or almost daily (at least 5 times per 
week) oral intake of iron supplementation (any dosage)”. Preeclampsia was diagnosed 
according international criteria. 25   
Questionnaires and laboratory examination: The IRLSSG score is a commonly used tool to 
measure to severity of the disease.2 Sleepiness was assessed using the Epworth Sleepiness 
Scale (ESS), with scores ≥ 10 indicating excessive daytime sleepiness (EDS).26  For IRLSSG 
and ESS we used validated Spanish versions.2,27 Laboratory examination included 
hemoglobin and  hematocrit.  
Statistics. Continuous data are expressed as means and standard deviation (SD), categorical 
variables as numbers and percentage. All analyses were performed with the Statistical 
Package for the Social Sciences (SPSS, version 17.0). For univariate analysis we used 
Student’s t-test (for numerical scale variables) and χ2-test (for nominal scale variables). 
Correlation analyses were performed using the Pearson coefficient. Significance was accepted 
at p < 0.05. 
Results  
Patients and RLS characteristics  
Mean age of all 218 expectant mothers was 26.7 years (SD +/- 6.3, range 15-45) and mean 
BMI was 24.8 (±4.8). Out of 218 patients, 40 (18.4%) fulfilled diagnostic criteria for RLS. 
Mean IRLSSG score was 16.6 (± 6.3), frequency of symptoms was 4.3 (± 2.5) days/ week and 
10/40 (25%) described RLS in previous pregnancies.  
Demographic, clinical characteristics and pregnancy / delivery complications in expectant  
mothers with and without RLS 
Expectant women with RLS (n=40) were matched for pregnant women without RLS (n=39). 
Between groups, there were no differences in age, actual BMI, BMI before pregnancy, 
hemoglobin, hematocrit or pregnancy/ delivery adverse events in general. Pregnant women  
had higher scores on ESS (p<0.01) than expectant women without RLS, took  
prophylactic daily iron supplementation (p=0.02) less frequently and suffered more often  
from preeclampsia (p=0.03).     
For further details please see table 1. 
 
Discussion 
RLS is a frequent, but often underestimated and underdiagnosed neurological disorder. In 
pregnancy, RLS often occurs in the 3rd trimester. Our results with a frequency of 18.4% of 
RLS in pregnancy are in line with published data on the prevalence of RLS in pregnancy (11-
30%).  
In a proportion of RLS patients (20-30%), excessive daytime sleepiness (EDS, as measured 
by ESS) occurs. Limited data indicate no particular demographic or clinical differences 
between “sleepy” and “non-sleepy” RLS patients. In our study, expecting mothers with RLS 
suffered more frequently from EDS. Clinically and laboratory (hemoglobin and hematocrit) 
analysis revealed similar findings between groups. Thus EDS is unlikely attributed to clinical 
or laboratory differences but to RLS. Other reasons for these differences include poor sleep or 
sleep deprivation.       
Iron supplementation was infrequent in pregnant women with RLS, possibly indicating 
consecutive lower iron levels that may have contributed to RLS. In a recent study by Siddiqui 
et al. 28, mean serum ferritin concentration in preeclamptics was higher than in normal 
pregnant women. In this study, no significant differences were found among hemoglobin 
concentration or hematocrit, either.     
This is the first study indicating a possible association between the occurrence of RLS in 
pregnancy and preeclampsia. Significantly more women with RLS suffered from 
preeclampsia compared to women without RLS (17.5% vs. 3%, p=0.03). Pathogenesis of 
preeclampsia still remains unclear. Different hypotheses for the occurrence of preeclampsia 
due to RLS include changes in iron status or disturbances in the blood pressure regulation by 
an elevated sympathetic activation, as RLS is associated with hypertension.   
Limitations: 
We have to acknowledge several limitations. We could not include laboratory measurements 
of iron status - ferritine. Thus relationship between iron deficiency in pregnancy and RLS 
remains mainly theoretical. Diagnosis of preeclampsia was made according diagnostic 
criteria. Detailed data on blood pressure levels and other symptoms of preeclampsia are 
lacking. During pregnancy, no patient has been treated for RLS and usually any treatment is 
reduced to a minimum. Nevertheless we had no data on medication of expecting mothers. 
Further, mean ESS scores were different between groups but did not reach cut off score for a 
pathologic degree of daytime sleepiness.  
In conclusion, pregnant women should be screened for RLS and EDS, as both are frequent 
complications of pregnancy. The role of RLS, iron and folate deficiency for the incidence of 
preeclampsia should be analyzed in larger studies.   
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Legends:  
Table 1  
Demographic, clinical characteristics and pregnancy / delivery complications in expectant 
mothers with and without RLS (matched controls) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1 
 
    RLS    Controls   p 
N    40    39 
Age [y]   27.2 ± 6.7   25.9 ± 5.6   n.s. 
BMI (actual)   30.5 ± 4.5    29.4 ± 6.8    n.s.  
BMI (before pregnancy) 24.7 ± 4    24.8 ± 5.6    n.s.   
IRLS     16.6 (± 6.3) 
ESS    10.6 ± 3.9    7.6 ± 3.1   <0.01 
Daily iron supplementation (n)  13/40 (32.5%)   18/39 (46.2%)   0.02  
Hemoglobin (g/dl)   9.8 ± 2.3    10.5 ± 1.5   n.s.  
Hematocrit (%)  32.5 ± 4    32.2 ± 4.6   n.s.  
Pregnancy or delivery   
associated adverse events (n)    9        3    n.s. 
-Preeclampsia (n)     7 (17.5%)       1 (3%)   0.03 
-Post-partum haemorrhage (n)  2        1    n.s. 
-Other (n)      0         1    n.s. 
BMI: Body-Mass-Index [kg/m2] 
ESS: Epworth Sleepiness Scale 
 
 
 
 
 
